K. Tangalakis et al., REGULATION OF STEROID HYDROXYLASE GENE-EXPRESSION IN THE OVINE FETAL ADRENAL-GLAND AT 0.4 GESTATION, Molecular and cellular endocrinology, 103(1-2), 1994, pp. 21-27
This study was designed to test the hypothesis that ACTH from the feta
l pituitary is a major regulator of adrenocortical steroid . hydroxyla
se gene expression in the ovine fetus at 0.4 (60-70 days) of gestation
. Pregnant ewes at 0.4 gestation received intravenous infusions of dex
amethasone (0.76 mg/h, n = 13) for 48 h. The rationale for this regime
was that some of the infused dexamethasone would cross the placenta a
nd act on the fetal pituitary to suppress ACTH release. Control animal
s received infusions,of saline (0.38 ml/h, n = 12) for 48 h. At the en
d of the infusion period, the animals were killed, umbilical vessel bl
ood taken for ACTH and cortisol analyses, and the fetal adrenal glands
taken for assessment of P-450(scc), P-450(17 alpha) and P-450(c21) le
vels using the techniques of hybridization histochemistry and RNase pr
otection assay. Dexamethasone treatment; decreased maternal and fetal
concentrations of ACTH to 29 +/- 10 and <20 pg/ml, respectively and co
rtisol concentrations to 3.5 +/- 0.6 and 3.2 +/- 0.8 nmol/l respective
ly. The adrenal glands from the dexamethasone-treated fetuses exhibite
d significantly lower levels of mRNA for P450(scc) (11% of control) an
d P-450(17 alpha) (2% of control). These results suggest that ACTH is
a major regulator of steroid hydroxylase gene expression and subsequen
t cortisol biosynthesis in vivo in the ovine fetus at 0.4 gestation.